Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

19.54

-0.87 (-4.26%)

At close: Nov 11, 2026, 4:00 PM EST

19.30

-0.24 (-1.23%)

After-hours: Nov 11, 2026, 5:37 PM EST

Legend Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	460.7	901.9	286.7	1,278	786.03	688.94
Short-Term Investments	391.8	46.7	835.9	30.34	54.02	193.46
Trading Asset Securities	-	-	-	0.66	185.6	-
Cash & Short-Term Investments	852.5	948.6	1,123	1,309	1,026	882.4
Cash Growth	-14.11%	-15.50%	-14.22%	27.60%	16.23%	74.49%
Accounts Receivable	-	13.1	6.4	101.43	0.28	50.5
Other Receivables	218.9	237.2	118.7	55.63	44.24	8.04
Receivables	218.9	250.3	125.1	157.06	44.52	58.55
Inventory	39.8	32	23.9	19.43	10.35	1.75
Prepaid Expenses	23.5	14.6	12.3	12.23	17.33	5.72
Other Current Assets	10.1	1.6	-	0.36	1.27	1.44
Total Current Assets	1,145	1,247	1,284	1,498	1,099	949.85
Property, Plant & Equipment	439.5	401.5	201.2	189.23	160.76	140.79
Long-Term Investments	-	-	-	4.36	-	4.71
Other Intangible Assets	-	-	-	4.06	3.41	4.68
Long-Term Accounts Receivable	-	-	-	-	0.4	-
Other Long-Term Assets	97.1	85.1	185.1	153.16	67.28	19.44
Total Assets	1,681	1,734	1,670	1,849	1,331	1,119

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	72	83	38.6	30.66	32.89	7.04
Accrued Expenses	115.5	123	64.5	61.58	152.73	104.38
Current Portion of Long-Term Debt	44.1	319.1	-	-	-	-
Current Portion of Leases	11.8	7.4	4.8	3.18	3.56	0.91
Current Income Taxes Payable	30	19.2	20.7	7.2	9.77	9.49
Current Unearned Revenue	-	11.3	47.4	53.08	0.45	0.3
Other Current Liabilities	16.2	73.4	101.7	60.73	98.38	107.08
Total Current Liabilities	289.6	636.4	277.7	216.42	297.79	229.2
Long-Term Debt	-	-	301.2	281.33	260.93	120.46
Long-Term Leases	111.5	87.2	44.6	44.17	20.04	1.59
Long-Term Unearned Revenue	-	-	6.1	55.27	7.66	1.87
Other Long-Term Liabilities	7.6	8	-	0.06	0.23	0.4
Total Liabilities	408.7	731.6	629.6	597.24	586.65	353.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.1	0.1	0.1	0.04	0.03	0.03
Additional Paid-In Capital	3,022	2,750	2,696	2,637	1,657	1,261
Retained Earnings	-1,928	-1,959	-1,662	-1,485	-966.46	-520.11
Comprehensive Income & Other	178.9	210.2	6.2	98.93	53.72	24.57
Shareholders' Equity	1,273	1,002	1,041	1,251	744.31	765.94
Total Liabilities & Equity	1,681	1,734	1,670	1,849	1,331	1,119

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	167.4	413.7	350.6	328.67	284.53	122.97
Net Cash (Debt)	685.1	534.9	772	980.05	741.12	759.43
Net Cash Growth	17.64%	-30.71%	-21.23%	32.24%	-2.41%	51.28%
Net Cash Per Share	3.65	2.90	4.22	5.57	4.66	5.39
Filing Date Shares Outstanding	193.97	184.94	183.65	181.91	165.07	154.23
Total Common Shares Outstanding	193.97	184.94	183.65	181.91	165.07	154.23
Working Capital	855.2	610.7	1,006	1,281	801.33	720.65
Book Value Per Share	6.56	5.42	5.67	6.88	4.51	4.97
Tangible Book Value	1,273	1,002	1,041	1,247	740.9	761.26
Tangible Book Value Per Share	6.56	5.42	5.67	6.86	4.49	4.94
Land	-	2.9	2.9	2.89	2.89	2.89
Buildings	-	66	65.5	65.54	45.08	16.01
Machinery	-	57.5	45	45.48	46.26	38.27
Construction In Progress	-	14.2	4.4	3.04	14.18	41.37
Leasehold Improvements	-	22.6	21.3	23.12	21.97	20.91

SEC Filings: 10-K · 10-Q